Advanced search
Publication Cover
Acta Oncologica Volume 61, 2022 - Issue 1
Journal homepage
1,241
Views
2
CrossRef citations to date
0
Altmetric
Original Articles: Prognosis, Prediction and Outcome

Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting

Sidsel Pedersena Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte, Herlev, DenmarkView further author information
,
Kirstine Ostenfeld Larsena Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte, Herlev, DenmarkView further author information
,
Alex Hørby Christensenb Department of Cardiology, Copenhagen University Hospital, Herlev and Gentofte, Herlev, Denmark;c Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkView further author information
,
Inge Marie Svanea Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte, Herlev, DenmarkORCID Iconhttps://orcid.org/0000-0002-9451-6037View further author information
ORCID Icon,
Bo Zerahnd Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Herlev and Gentofte, Herlev, DenmarkView further author information
&
Eva Ellebaeka Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev and Gentofte, Herlev, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6748-9232View further author information
ORCID Icon
Pages 45-51 | Received 13 Aug 2021, Accepted 06 Oct 2021, Published online: 19 Oct 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Joanna Vitfell-Rasmussen, Anders Krarup-Hansen, Merete Vaage-Nilsen, Thomas Kümler & Bo Zerahn. (2022) Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin. Acta Oncologica 61:7, pages 801-808.
Read now

Articles from other publishers (1)

Tyler C. Beck, Dimitrios C. Arhontoulis, Jordan E. Morningstar, Nathaniel Hyams, Andrew Stoddard, Kendra Springs, Rupak Mukherjee, Kris Helke, Lilong Guo, Kelsey Moore, Cortney Gensemer, Rachel Biggs, Taylor Petrucci, Jennie Kwon, Kristina Stayer, Natalie Koren, Andrew Harvey, Heather Holman, Jaclyn Dunne, Diana Fulmer, Ayesha Vohra, Le Mai, Sarah Dooley, Julianna Weninger, Silvia Vaena, Martin Romeo, Robin C. Muise-Helmericks, Ying Mei & Russell A. Norris. (2022) Cellular and Molecular Mechanisms of MEK1 Inhibitor–Induced Cardiotoxicity. JACC: CardioOncology 4:4, pages 535-548.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.